Literature DB >> 14985499

Transient improvement of aphasia with zolpidem.

Laurent Cohen, Bassem Chaaban, Marie-Odile Habert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14985499     DOI： 10.1056/NEJM200402263500922

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  25 in total

1.  High-dose zolpidem withdrawal seizure in a patient with spinocerebellar ataxia.

Authors:  Cheng-Chen Chang; Wen-Fang Wang
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 2.  Pharmacotherapy for disorders of consciousness: are 'awakening' drugs really a possibility?

Authors:  Rosella Ciurleo; Placido Bramanti; Rocco Salvatore Calabrò
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

3.  α2-Adrenergic stimulation of the ventrolateral preoptic nucleus destabilizes the anesthetic state.

Authors:  Hilary S McCarren; Michael R Chalifoux; Bo Han; Jason T Moore; Qing Cheng Meng; Nina Baron-Hionis; Madineh Sedigh-Sarvestani; Diego Contreras; Sheryl G Beck; Max B Kelz
Journal:  J Neurosci       Date:  2014-12-03       Impact factor: 6.167

4.  Translating concepts of neural repair after stroke: Structural and functional targets for recovery.

Authors:  Robert W Regenhardt; Hajime Takase; Eng H Lo; David J Lin
Journal:  Restor Neurol Neurosci       Date:  2020       Impact factor: 2.406

5.  FTD with catatonia-like signs that temporarily resolved with zolpidem.

Authors:  Shuichi Isomura; Akira Monji; Kensuke Sasaki; Shingo Baba; Toshiaki Onitsuka; Tomoyuki Ohara; Yoshito Mizoguchi; Takahiro A Kato; Hideki Horikawa; Yoshihiro Seki; Shigenobu Kanba
Journal:  Neurol Clin Pract       Date:  2013-08

6.  Zolpidem reduces the blood oxygen level-dependent signal during visual system stimulation.

Authors:  Stephanie C Licata; Steven B Lowen; George H Trksak; Robert R Maclean; Scott E Lukas
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-05-30       Impact factor: 5.067

Review 7.  The Effectiveness of Zolpidem for the Treatment of Disorders of Consciousness.

Authors:  Calvin Tucker; Kirsten Sandhu
Journal:  Neurocrit Care       Date:  2016-06       Impact factor: 3.210

Review 8.  Awakenings and awareness recovery in disorders of consciousness: is there a role for drugs?

Authors:  Francesca Pistoia; Elisa Mura; Stefano Govoni; Massimo Fini; Marco Sarà
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

Review 9.  Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem.

Authors:  Romy Hoque; Andrew L Chesson
Journal:  J Clin Sleep Med       Date:  2009-10-15       Impact factor: 4.062

10.  The flavonoid, 2'-methoxy-6-methylflavone, affords neuroprotection following focal cerebral ischaemia.

Authors:  Andrew N Clarkson; Lily Boothman-Burrell; Zita Dósa; Raghavendra Y Nagaraja; Liang Jin; Kim Parker; Petra S van Nieuwenhuijzen; Silke Neumann; Emma K Gowing; Navnath Gavande; Philip K Ahring; Mai M Holm; Jane R Hanrahan; Joseph A Nicolazzo; Kimmo Jensen; Mary Chebib
Journal:  J Cereb Blood Flow Metab       Date:  2018-01-29       Impact factor: 6.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.